The P2X7 receptor in inflammatory diseases: angel or demon?
LEB Savio, P de Andrade Mello… - Frontiers in …, 2018 - frontiersin.org
Under physiological conditions, adenosine triphosphate (ATP) is present at low levels in the
extracellular milieu, being massively released by stressed or dying cells. Once outside the …
extracellular milieu, being massively released by stressed or dying cells. Once outside the …
The P2X7 receptor: central hub of brain diseases
R Andrejew, Á Oliveira-Giacomelli… - Frontiers in Molecular …, 2020 - frontiersin.org
The P2X7 receptor is a cation channel activated by high concentrations of adenosine
triphosphate (ATP). Upon long-term activation, it complexes with membrane proteins forming …
triphosphate (ATP). Upon long-term activation, it complexes with membrane proteins forming …
The P2X7 receptor channel: recent developments and the use of P2X7 antagonists in models of disease
The P2X7 receptor is a trimeric ATP-gated cation channel found predominantly, but not
exclusively, on immune cells. P2X7 activation results in a number of downstream events …
exclusively, on immune cells. P2X7 activation results in a number of downstream events …
P2X7 in cancer: from molecular mechanisms to therapeutics
R Lara, E Adinolfi, CA Harwood, M Philpott… - Frontiers in …, 2020 - frontiersin.org
P2X7 is a transmembrane receptor expressed in multiple cell types including neurons,
dendritic cells, macrophages, monocytes, B and T cells where it can drive a wide range of …
dendritic cells, macrophages, monocytes, B and T cells where it can drive a wide range of …
Irradiation causes senescence, ATP release, and P2X7 receptor isoform switch in glioblastoma
Glioblastoma (GBM) is the most lethal brain tumor in adults. Radiation, together with
temozolomide is the standard treatment, but nevertheless, relapse occurs in nearly all cases …
temozolomide is the standard treatment, but nevertheless, relapse occurs in nearly all cases …
Mechanisms of Invasion in Glioblastoma: Extracellular Matrix, Ca2+ Signaling, and Glutamate
Glioblastoma (GBM) is the most common and malignant form of primary brain tumor with a
median survival time of 14–16 months in GBM patients. Surgical treatment with …
median survival time of 14–16 months in GBM patients. Surgical treatment with …
P2X7 receptor as a therapeutic target
E De Marchi, E Orioli, D Dal Ben, E Adinolfi - Advances in protein chemistry …, 2016 - Elsevier
P2X7 receptor is an ATP-gated cation channel that upon agonist interaction leads to cellular
influx of Na+ and Ca 2+ and efflux of K+. P2X7 is expressed by a wide variety of cells and its …
influx of Na+ and Ca 2+ and efflux of K+. P2X7 is expressed by a wide variety of cells and its …
Multifaceted effects of extracellular adenosine triphosphate and adenosine in the tumor–host interaction and therapeutic perspectives
P de Andrade Mello, R Coutinho-Silva… - Frontiers in …, 2017 - frontiersin.org
Cancer is still one of the world's most pressing health-care challenges, leading to a high
number of deaths worldwide. Immunotherapy is a new developing therapy that boosts …
number of deaths worldwide. Immunotherapy is a new developing therapy that boosts …
Alternatively spliced isoforms of the P2X7 receptor: structure, function and disease associations
SKF De Salis, L Li, Z Chen, KW Lam… - International Journal of …, 2022 - mdpi.com
The P2X7 receptor (P2X7R) is an ATP-gated membrane ion channel that is expressed by
multiple cell types. Following activation by extracellular ATP, the P2X7R mediates a broad …
multiple cell types. Following activation by extracellular ATP, the P2X7R mediates a broad …
Antagonism of the ATP-gated P2X7 receptor: a potential therapeutic strategy for cancer
Abstract The P2X receptor 7 (P2X7R) is a plasma membrane receptor sensing extracellular
ATP associated with a wide variety of cellular functions. It is most commonly expressed on …
ATP associated with a wide variety of cellular functions. It is most commonly expressed on …